Here’s what you should know:
1. Orthotaxy is in the midst of developing a differentiated robotic-assisted surgery solution.
2. The proprietary technology is in early-stage development and will address total and partial knee replacements.
3. Johnson & Johnson will leverage the technology to develop cost-effective, time-efficient, user-friendly orthopedic offerings.
4. J&J’s DePuy Synthes Company Group Chairman Ciro Rӧmer said, “Our goal is to bring to market a robotic-assisted surgery technology that is an integral part of a comprehensive orthopaedics platform, delivering value to patients, physicians and healthcare providers across the episode of care.”
More articles on supply chain:
5 key observations on NJ ASC landscape post-‘One-Room Bill”
To prevent the spread of norovirus at the Olympics, athletes told to fist-bump, not shake hands: 4 things to know
Partner at Seaside Surgery Center receives board certification — 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
